ES431601A1 - Un procedimiento para preparar una formulacion que contiene prostaglandina del grupo e estable. - Google Patents

Un procedimiento para preparar una formulacion que contiene prostaglandina del grupo e estable.

Info

Publication number
ES431601A1
ES431601A1 ES431601A ES431601A ES431601A1 ES 431601 A1 ES431601 A1 ES 431601A1 ES 431601 A ES431601 A ES 431601A ES 431601 A ES431601 A ES 431601A ES 431601 A1 ES431601 A1 ES 431601A1
Authority
ES
Spain
Prior art keywords
group
containing formulation
prostaglandin
stable prostaglandin
stable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES431601A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP12366973A external-priority patent/JPS5071816A/ja
Priority claimed from JP7258574A external-priority patent/JPS511626A/ja
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of ES431601A1 publication Critical patent/ES431601A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES431601A 1973-11-02 1974-11-02 Un procedimiento para preparar una formulacion que contiene prostaglandina del grupo e estable. Expired ES431601A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12366973A JPS5071816A (es) 1973-11-02 1973-11-02
JP7258574A JPS511626A (en) 1974-06-25 1974-06-25 Anteina purosutaguranjin e ruiseizaino seizoho

Publications (1)

Publication Number Publication Date
ES431601A1 true ES431601A1 (es) 1977-04-16

Family

ID=26413714

Family Applications (1)

Application Number Title Priority Date Filing Date
ES431601A Expired ES431601A1 (es) 1973-11-02 1974-11-02 Un procedimiento para preparar una formulacion que contiene prostaglandina del grupo e estable.

Country Status (5)

Country Link
US (1) US4036954A (es)
DE (1) DE2451161A1 (es)
ES (1) ES431601A1 (es)
FR (1) FR2249658B1 (es)
GB (3) GB1489779A (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA787353B (en) 1978-05-17 1980-08-27 Wellcome Found Pharmaceutical formulations
SE431821B (sv) * 1979-01-29 1984-03-05 Perstorp Ab Lagringsstabilt, prostaglandininnehallande medicinskt preparat
DE2925009A1 (de) * 1979-06-21 1981-01-08 Basf Ag Zubereitung fuer substanzen, verfahren zu deren herstellung und deren verwendung
US4675182A (en) * 1983-02-12 1987-06-23 Bayer Aktiengesellschaft Complexes of prostaglandins
US4889862A (en) * 1986-08-28 1989-12-26 E. I. Du Pont De Nemours And Company Freeze-dried pharmaceutical compositions of phenylquinoline carboxylic acids
JPH03220201A (ja) * 1988-11-18 1991-09-27 Eisai Co Ltd プロスタグランジン類と多糖類の結合体
US5904935A (en) * 1995-06-07 1999-05-18 Alza Corporation Peptide/protein suspending formulations
US7303768B2 (en) * 1998-07-24 2007-12-04 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
US7772220B2 (en) * 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
US20070072828A1 (en) * 1998-07-24 2007-03-29 Yoo Seo H Bile preparations for colorectal disorders
US20050158408A1 (en) * 1998-07-24 2005-07-21 Yoo Seo H. Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
US7145125B2 (en) 2003-06-23 2006-12-05 Advanced Optical Technologies, Llc Integrating chamber cone light using LED sources
US20050153946A1 (en) * 2003-12-24 2005-07-14 Collegium Pharmaceuticals, Inc. Temperature-stable formulations, and methods of development thereof
DE602005019582D1 (de) * 2004-08-30 2010-04-08 Seo Hong Yoo Nervenschutzwirkung von aufgelöster udca bei einem fokalen ischämischen modell
CA2584184A1 (en) * 2004-10-15 2006-04-27 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
DE602005025391D1 (de) * 2004-11-01 2011-01-27 Seo Hong Yoo Verfahren und zusammensetzungen zur verringerung der neurodegeneration bei amyotrophischer lateralsklerose
US7560489B2 (en) * 2006-10-11 2009-07-14 Nexmed Holdings, Inc. Stabilized prostaglandin E composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS503362B1 (es) * 1970-06-10 1975-02-04
US3826823A (en) * 1972-09-25 1974-07-30 Syntex Inc Stabilized prostaglandin preparations
US3851052A (en) * 1972-11-08 1974-11-26 Pfizer Stabilized e-series prostaglandins
US3917864A (en) * 1973-02-12 1975-11-04 Sultanali M M Karim Use of prostaglandins E and F for induction of labor
US3903297A (en) * 1973-11-01 1975-09-02 Upjohn Co Method of treatment and prophylaxis of gastric hypersecretion and gastric and duodenal ulcers using prostaglandin analogs
US3954787A (en) * 1974-06-18 1976-05-04 Pfizer Inc. Stabilized E-series prostaglandins

Also Published As

Publication number Publication date
GB1489780A (en) 1977-10-26
DE2451161A1 (de) 1975-05-07
FR2249658A1 (es) 1975-05-30
US4036954A (en) 1977-07-19
FR2249658B1 (es) 1980-02-08
GB1489778A (en) 1977-10-26
GB1489779A (en) 1977-10-26

Similar Documents

Publication Publication Date Title
ES431601A1 (es) Un procedimiento para preparar una formulacion que contiene prostaglandina del grupo e estable.
YU41540B (en) Process for preparing bis-(dihydroxy-propilamides) of 5-hydroxy-propionylamido-2,4,6-triido-isophthalic acid, which are readily soluble in water
DE3362784D1 (en) Process for preparing free-flowing ethylcellulose microcapsules
ES400927A1 (es) Un procedimiento para preparar un dentifrico estable.
GB1504070A (en) Prostaglandin salt
ES418924A1 (es) Procedimiento para la obtencion de 13, 14-dihidroprosta- glandinas.
GB1320032A (en) Imidazole derivatives
ES428949A1 (es) Procedimiento para la preparacion de derivados de acidos quinolin-8-carboxilicos.
GB1447456A (en) Process for preparing desmosterols
GB1513701A (en) Watersoluble dye composition
ES451880A1 (es) Procedimiento de preparacion de una nueva composicion den- tifrica.
GB1429458A (en) Tetrisocyanate composition and process therefor
ES415719A1 (es) Metodo de preparacion de compuestos complejos de acidos aminodicarboxilicos.
GB1490290A (en) Preparation of penicillanic acid derivatives
GB1421580A (en) Production of benzylamine derivatives
GB1169990A (en) Phenoxy Propan-2-Olamines
ES461252A1 (es) Un procedimiento para la produccion de 4,5-epoxi-tetrahidro-piran-3-ona.
ES428011A1 (es) Procedimiento para la preparacion de 2-amino-3,5-dibromo- bencilamina.
GB1137612A (en) Proscillaridin derivatives
ES394667A1 (es) Procedimiento de preparacion de derivados del acido prosta-noico.
ES429817A1 (es) Procedimiento para preparar derivados del acido tricloro- acetamido-6 penicilanico.
ES386715A1 (es) Procedimiento para la preparacion de nuevos derivados de tiepina.
GB1292728A (en) Novel glucuronic acid derivatives and process for the preparation thereof
GB1237338A (en) Improvements in the preparation of polyethylene terephthalate
GB1427762A (en) Process for the manufacture of steroid fluorohydrines